Bridging Interventional Development Gaps researchers will support two projects aimed at finding treatments for diabetic keratopathy — a condition that often leads to blindness — and severe heart attacks.
Read about recent awards for the Rare Diseases Clinical Research Network program, a global translational research collaboration that includes NCATS, new pre-clinical research projects and more.
NCATS researchers will begin work on three new pre-clinical drug development projects for malaria, Lassa fever and two blood disorders through the Therapeutics for Rare and Neglected Diseases program.
NIH funds 22 consortia and a data center to study more than 200 rare diseases.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Eleven institutions will refine 3-D human tissue chips to test the safety of drugs.
Apply by Jan. 15, 2015, for the Clinical and Translational Science Awards program.
- Publication of Notice of Proposed Rulemaking for Clinical Trials Registration and Results Submission under FDAAA
- NIH Request for Public Comments on the Draft NIH Policy on Dissemination of NIH-Funded Clinical Trial Information
- Request for Information (RFI): Input on Direction of the Second Phase of the "Illuminating the Druggable Genome" Program
- More Funding & Notices...
- Providers' Perspectives on Male Involvement in Family Planning in the Context of a Cluster-Randomized Controlled Trial • AIDS Care
- Clinic Software to Support Global Rare Disease Registry • Marshfield Clinic
- Scientists Study Effects of Sunlight to Reduce Number of Nearsighted Kids • The Ohio State University
- More News & Events...
IN THE SPOTLIGHT
Small Business Funding Opportunities
NCATS participates in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs to support companies developing new therapies and diagnostics to help move bench research to clinical practice and commercialization.